SCHEMBL31525852

SCHEMBL31525852

C=C(C)COc1cncc(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 7/20 0.46
ALDH1A1 P00352 6/20 0.46
HTT P42858 5/20 0.46
TSHR P16473 4/20 0.46
HPGD P15428 2/20 0.46
MAPT P10636 10/20 0.44
MAPK1 P28482 5/20 0.44
KDM4E B2RXH2 4/20 0.44
KMT2A Q03164 10/20 0.43
IDE P14735 1/20 0.43
ADAM17 P78536 1/20 0.43
MEN1 O00255 8/20 0.43
TP53 P04637 6/20 0.43
USP2 O75604 4/20 0.43
ALOX12 P18054 3/20 0.43
HSP90AA1 P07900 1/20 0.43
LMNA P02545 4/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
MAPK10 P53779 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26152004 0.78 ATM (0.51) ALDH1A1MAPTMAPK1LMNAGAA
SCHEMBL744752 0.76 CYP1A1 (0.61) ALDH1A1CYP1A2CYP3A4CYP2C9CYP1A1
SCHEMBL1072731 0.75 GPR174 (0.51) NPSR1ALDH1A1HTTTSHRHPGD
SCHEMBL10781062 0.75 CYP11B1 (0.58) ALDH1A1HTTLMNACYP1A2CYP3A4
SCHEMBL16237268 0.73 CYP1A1 (0.45) ALDH1A1CYP1A2CYP3A4CYP2C9CYP1A1
SCHEMBL15780514 0.72 MAPT (0.38) NPSR1ALDH1A1HTTTSHRHPGD
SCHEMBL23461674 0.72 CHRNB2 (0.48) ALDH1A1MAPK1CYP1A2CYP3A4CYP2C9
SCHEMBL29996980 0.72 CHRNB2 (0.48) ALDH1A1MAPK1CYP1A2CYP3A4CYP2C9
SCHEMBL11144126 0.71 CHRNB2 (0.53) NPSR1MAPTRAB9A
SCHEMBL9622079 0.71 LMNA (0.52) NPSR1ALDH1A1HTTTSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122152-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-04-17 US disclosed
WO-2025068943-A1 KAT6 INHIBITORS BEIGENE SWITZERLAND GMBH (CH) 2025-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122152-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT7 NPSR1 3120/4885ALDH1A1 3555/4885HTT 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.